Investigation of the Therapeutic Effects of Chloroquine in Adriamycin-Induced Hepatotoxicity

Akin, Ali Tuğrul; Kaymak, Emin; Öztürk, Emel; Karabulut, Derya; Kuloğlu, Nurhan; Ceylan, Tayfun; Toluk, Ayşe

doi:10.2478/ebtj-2021-0003

Abstract

The aim of this study is to investigate the therapeutic effects of Chloroquine (CLQ) against Adriamycin (ADR) induced hepatotoxicity. ADR is a chemotherapeutic agent used in the treatment of many cancer types, but it causes hepatotoxicity. CLQ is used as an anti-inflammatory drug in the treatment of malaria, rheumatoid arthritis, and pneumonia caused by Covid-19. Rats were divided into four groups: Control group, ADR group (2 mg/kg Adriamycin, one in three days for 30 days, i.p.), CLQ group (50 mg/kg Chloroquine, per day for 30 days, i.p.), ADR+CLQ (2 mg/kg Adriamycin, one in three days for 30 days, i.p. and 50 mg/ kg Chloroquine, per day for 30 days, i.p.). Animals were sacrificed, and liver tissues were extracted for further examinations. Histopathological changes in liver tissues were scored and IL-17 immunostaining was performed to determine the expression levels among experimental groups. Bodyweights in the ADR group decreased significantly compared to the Control group and CLQ group. Furthermore, bodyweight in ADR+CLQ group was significantly higher compared to ADR group. The histopathological score was significantly higher in ADR group when compared to Control and CLQ group while CLQ administrations reduced the damage induced by ADR in the ADR+CLQ group. IL-17 immunoreactivity was considerably increased in the ADR group. On the other hand, IL-17 expressions of ADR+CLQ were substantially less compared to ADR group. We suggest that CLQ can be used as a therapeutic agent to reduce the detrimental effects of ADR, thanks to its anti-inflammatory properties.

References

Ölgen S BaI, Nebioğlu D. Angiogenesis and New Aspects of Cancer Chemotherapy. Journal of Faculty of Pharmacy of Ankara University. 2002;31 (3):193-214.
Search in Google Scholar Back to article
Meister LA MALeocctCPP, 102-131. Late effects of childhood cancer therapy. Current Problems in Pediatrics 1993 23:102-31.
Search in Google Scholar Back to article
Doroshow JH, Locker GY, Myers CE. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest. 1980;65(1):128-35.
Search in Google Scholar Back to article
Kısmet E DE, Yurttutan N, Berberoğlu S, Karademir S, Aydın Hİ, Kalman S, Köseoğlu V. Serum BNP levels in children treated with Doxorubicin for their solif tumors. Gülhane Tıp Dergisi 2004;46(1):38-42.
Search in Google Scholar Back to article
Liu Y, Yang Y, Liu X, Jiang T. Quantification of pegylated liposomal doxorubicin and doxorubicinol in rat plasma by liquid chromatography/electrospray tandem mass spectroscopy: Application to preclinical pharmacokinetic studies. Talanta. 2008;74(4):887-95.
Search in Google Scholar Back to article
Wallace K. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacology and Toxicology. 2003;93(3):105-15.
Search in Google Scholar Back to article
Li J, Li L, Li X, Wu S. Long noncoding RNA LINC00339 aggravates doxorubicin-induced cardiomyocyte apoptosis by targeting MiR-484. Biochem Biophys Res Commun. 2018;503(4):3038-43.
Search in Google Scholar Back to article
El-Sayed EM, Mansour AM, El-Sawy WS. Protective effect of proanthocyanidins against doxorubicin-induced nephrotoxicity in rats. J Biochem Mol Toxicol. 2017;31(11).
Search in Google Scholar Back to article
Omobowale TO, Oyagbemi AA, Ajufo UE, Adejumobi OA, Ola-Davies OE, Adedapo AA, et al. Ameliorative Effect of Gallic Acid in Doxorubicin-Induced Hepatotoxicity in Wistar Rats Through Antioxidant Defense System. J Diet Suppl. 2018;15(2):183-96.
Search in Google Scholar Back to article
Hozayen W. Effect of hesperidin and rutin on doxorubicin induced testicular toxicity in male rats. International Journal of Food Sciences and Nutrition. 2012;1:31-42.
Search in Google Scholar Back to article
Fimognari C, Sestili P, Lenzi M, Bucchini A, Cantelli-Forti G, Hrelia P. RNA as a new target for toxic and protective agents. Mutat Res. 2008;648(1-2):15-22.
Search in Google Scholar Back to article
Pang B, Qiao X, Janssen L, Velds A, Groothuis T, Kerkhoven R, et al. Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nat Commun. 2013;4:1908.
Search in Google Scholar Back to article
Bilgic S, Ozgocmen M. The protective effect of misoprostol against doxorubicin induced liver injury. Biotech Histochem. 2019;94(8):583-91.
Search in Google Scholar Back to article
Liu J, Qu W, Kadiiska MB. Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicol Appl Pharmacol. 2009;238(3):209-14.
Search in Google Scholar Back to article
Noronha IL, Niemir Z, Stein H, Waldherr R. Cytokines and growth factors in renal disease. Nephrol Dial Transplant. 1995;10(6):775-86.
Search in Google Scholar Back to article
Azuma MM, Gomes-Filho JE, Prieto AKC, Samuel RO, de Lima VMF, Sumida DH, et al. Diabetes increases interleukin-17 levels in periapical, hepatic, and renal tissues in rats. Arch Oral Biol. 2017;83:230-5.
Search in Google Scholar Back to article
Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002;71(1):1-8.
Search in Google Scholar Back to article
Yu JJ, Gaffen SL. Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci. 2008;13:170-7.
Search in Google Scholar Back to article
He Y, Yang Z, Li J, Li E. Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cells. Exp Mol Pathol. 2020;113:104371.
Search in Google Scholar Back to article
Zhang S, You ZQ, Yang L, Li LL, Wu YP, Gu LQ, et al. Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators. BMC Complement Altern Med. 2019;19(1):317.
Search in Google Scholar Back to article
Liu Y, Su L, Lin Q, Han Y, You P, Fan Q. Induction of C-Mip by IL-17 Plays an Important Role in Adriamycin-Induced Podocyte Damage. Cell Physiol Biochem. 2015;36(4):1274-90.
Search in Google Scholar Back to article
Ma Y, Aymeric L, Locher C, Mattarollo SR, Delahaye NF, Pereira P, et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med. 2011;208(3):491-503.
Search in Google Scholar Back to article
Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y. Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol. 2012;42(2):145-53.
Search in Google Scholar Back to article
Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, et al. UK malaria treatment guidelines. J Infect. 2007;54(2):111-21.
Search in Google Scholar Back to article
Rainsford KD, Parke AL, Clifford-Rashotte M, Kean WF. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology. 2015;23(5):231-69.
Search in Google Scholar Back to article
Huang M, Tang T, Pang P, Li M, Ma R, Lu J, et al. Treating COVID-19 with Chloroquine. J Mol Cell Biol. 2020;12(4):322-5.
Search in Google Scholar Back to article
Lehmann GL, Carreras FI, Soria LR, Gradilone SA, Marinelli RA. LPS induces the TNF-alpha-mediated down-regulation of rat liver aquaporin-8: role in sepsis-associated cholestasis. Am J Physiol Gastrointest Liver Physiol. 2008;294(2):G567-75.
Search in Google Scholar Back to article
Yang M, Cao L, Xie M, Yu Y, Kang R, Yang L, et al. Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis. Biochem Pharmacol. 2013;86(3):410-8.
Search in Google Scholar Back to article
Shivakumar P, Rani MU, Reddy AG, Anjaneyulu Y. A study on the toxic effects of Doxorubicin on the histology of certain organs. Toxicol Int. 2012;19(3):241-4.
Search in Google Scholar Back to article
Long L, Yang X, Southwood M, Lu J, Marciniak SJ, Dunmore BJ, et al. Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation. Circ Res. 2013;112(8):1159-70.
Search in Google Scholar Back to article
Bayatli F, Akkus D, Kilic E, Saraymen R, Sonmez MF. The protective effects of grape seed extract on MDA, AOPP, apoptosis and eNOS expression in testicular torsion: an experimental study. World J Urol. 2013;31(3):615-22.
Search in Google Scholar Back to article
Karabulut D, Ulusoy HB, Kaymak E, Sönmez MF. Therapeutic effects of pentoxifylline on diabetic heart tissue via NOS. Anatolian journal of cardiology. 2016;16(5):310-5.
Search in Google Scholar Back to article
Öztürk E, Kaymak E, Akin AT, Karabulut D, Ünsal HM, Yakan B. Thymoquinone is a protective agent that reduces the negative effects of doxorubicin in rat testis. Hum Exp Toxicol. 2020:960327120924108.
Search in Google Scholar Back to article
Afsar T, Razak S, Almajwal A. Effect of Acacia hydaspica R. Parker extract on lipid peroxidation, antioxidant status, liver function test and histopathology in doxorubicin treated rats. Lipids in Health and Disease. 2019;18(1):126.
Search in Google Scholar Back to article
Kuzu M, Yıldırım S, Kandemir FM, Küçükler S, Çağlayan C, Türk E, et al. Protective effect of morin on doxorubicin-induced hepatorenal toxicity in rats. Chem Biol Interact. 2019;308:89-100.
Search in Google Scholar Back to article
Song S, Chu L, Liang H, Chen J, Liang J, Huang Z, et al. Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Via Regulation of Sirt1/FOXO1/NF κb Signal. Front Pharmacol. 2019;10:1030.
Search in Google Scholar Back to article
Doğanyiğit Z, Yakan B, Okan A, Silici S. Antioxidative role of propolis on LPS induced renal damage. The EuroBiotech Journal. 2020;4:156-60.
Search in Google Scholar Back to article
Karabulut D, Ozturk E, Kuloglu N, Akin AT, Kaymak E, Yakan B. Effects of vitamin B12 on methotrexate hepatotoxicity: evaluation of receptor-interacting protein (RIP) kinase. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(12):2473-80.
Search in Google Scholar Back to article
Akin A. T. KE, Karabulut D. , Doğanyiğit Z., Ceylan T., Toluk A. , Özdamar S. Comparison of the acute and cumulative dose administrations in doxorubicin-induced hepatotoxicity via evaluation of the histopathological changes and inflammation in rats. Experimental and Applied Medical Science. 2020;1(3):73-81.
Search in Google Scholar Back to article
Doğanyiğit Z, Silici S, Demirtaş A, Kaya E, 1. Kaymak E. Determination of histological, immunohistochemical and biochemical effects of acute and chronic grayanotoxin III administration in different doses in rats. Environ Sci Pollut Res Int. 2019;26(2):1323-35.
Search in Google Scholar Back to article
Çakır M, Tekin S, Doğanyiğit Z, Çakan P, Kaymak E. The protective effect of cannabinoid type 2 receptor activation on renal ischemia-reperfusion injury. Mol Cell Biochem. 2019;462(1-2):123-32.
Search in Google Scholar Back to article
Sönmez MF, Ozdemir Ş, Guzel M, Kaymak E. The ameliorative effects of vinpocetine on apoptosis and HSP-70 expression in testicular torsion in rats. Biotech Histochem. 2017;92(2):92-9.
Search in Google Scholar Back to article

Investigation of the Therapeutic Effects of Chloroquine in Adriamycin-Induced Hepatotoxicity

Abstract

Paradigm

My account